| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |